Jackson, W
Hornik, C P
Messina, J A
Guglielmo, K
Watwe, A
Delancy, G
Valdez, A
MacArthur, T
Peter-Wohl, S
Smith, P B
Tolia, V N
Laughon, M M
Article History
Received: 25 January 2017
Accepted: 3 March 2017
First Online: 6 April 2017
Competing interests
: CPH receives salary support for research from the National Center for Advancing Translational Sciences of the National Institutes of Health (UL1TR001117); PBS receives salary support for research from the National Institutes of Health (NIH-1R21HD080606-01A1) and the National Institute for Child Health and Human Development (HHSN275201000003I); SP-W receives salary support for research from the Gerber Foundation and the National Institute of Allergy and Infectious Diseases (R01 AI1000067-01; principal investigator (PI) De Paris); MML is supported by the US government for his work in pediatric and neonatal clinical pharmacology by <i>Eunice Kennedy Shriver</i> National Institute of Child Health and Human Development (Contract HHSN267200700051C; PI Benjamin), the Food and Drug Administration Office of Orphan Product Development (R01 FD005101; PI Laughon) and the National Heart, Lung and Blood Institute (R34 HL124038; PI Laughon).
Free to read: This content has been made available to all.